BUY Eris Lifesciences Limited — Elara Capital
byElara CapitalHorizon: NA (inferred 1 year)28 Aug 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·29 Jul · 3mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·22 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Eris Lifesciences
- BUY — Pawan Maheshwari8 Sept 2026 · ~2 weeks · target ₹1,360 · Target hit
- BUY — Sandeep Jain, Tradeswift7 Sept 2026 · ~2 weeks · target ₹1,430 · Expired
- BUY — HDFC Securities29 Jul 2026 · ~1 year · target ₹1,730 · Active
- BUY — Sandeep Jain, Tradeswift16 Jul 2026 · ~1 year · target ₹1,650 · Active
- BUY — Prabhudas Lilladher9 Jul 2026 · ~3 months · target ₹1,750 · Expired
More from Elara Capital
- BUY Aditya Birla Sun Life AMC22 Oct 2026 · ~1 year · target ₹1,100 · Active
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹922 · Active
- BUY UltraTech Cement21 Oct 2026 · ~1 year · target ₹13,006 · Active
- BUY Bajaj Finance21 Oct 2026 · ~1 year · target ₹1,350 · Active
- BUY Punjab National Bank19 Oct 2026 · ~1 year · target ₹140 · Active

